- 全部删除
- 您的购物车当前为空
P2Y14R antagonist 4 (Compound 25l) 是一种口服活性的P2Y14R拮抗剂,IC50为5.6 nM,优于其他PPTN结合亲和力。P2Y14R antagonist 4 具有抗炎作用,能够减少LPS诱导的促炎细胞因子(IL-1β、IL-6 和 TNF-α)的释放。
P2Y14R antagonist 4 (Compound 25l) 是一种口服活性的P2Y14R拮抗剂,IC50为5.6 nM,优于其他PPTN结合亲和力。P2Y14R antagonist 4 具有抗炎作用,能够减少LPS诱导的促炎细胞因子(IL-1β、IL-6 和 TNF-α)的释放。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | Compound 25l, also known as P2Y14R antagonist 4, is an orally active antagonist of the P2Y14R receptor with an IC50 of 5.6 nM. It exhibits higher binding affinity for P2Y14R compared to other PPTN receptors. P2Y14R antagonist 4 also possesses anti-inflammatory properties, reducing the release of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) induced by LPS. |
靶点活性 | P2Y14 Receptor:5.6 nM |
分子量 | 532.574 |
分子式 | C27H27F3N2O4S |
CAS No. | 3081687-67-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容